Get in touch with one of our Xperts.
Empowering Dutch Biotech: Navigating Innovation and Market Success with the Dutch Regional Development Agencies on November 21, 2024 Ronald van der Geest, partner at 3D-PharmXchange, has been invited to attend the Life Sciences & Health ROMs Day, to advise the regional investment agencies on how to become even more effective in bringing Dutch Biotech ventures continue reading…
In recent years, the biotechnology industry has seen a transformative shift towards patient-driven drug development. At 3D-PharmXchange, we have experienced firsthand the impact that patient involvement can have on the development of new therapies. It has already been well described that patients bring a unique perspective that often reshapes the design of clinical trials. Their continue reading…
Inez de Greef elected as fellow of the Netherlands Academy of Engineering We are thrilled to announce that Inez de Greef, CEO of Treeway and co-founder and Managing Partner of 3D-PharmXchange, has been elected as a fellow of the Netherlands Academy of Engineering (NAE). The NAE brings together top experts in technological sciences and applied continue reading…
Knowledge for Growth, Europe’s leading conference in the field of life sciences, is set to take place in Antwerp, Belgium on June 1, 2023. This exceptional event will bring together the most influential individuals from the European life sciences community. Attendees will include key decision makers from the biotech, pharmaceutical, and MedTech industries, as well continue reading…
Fast-track drug development: taking the highway or the roundabout? In a race against time, costs and competitors, the pharmaceutical industry finds itself at a crossroads. As the world demands faster drug development, scientists embarking on product development are faced with a crucial decision: do we take the highway or the roundabout? Join us as we continue reading…
A successful drug development strategy is a well-designed and dynamic process. Making sure regulatory requirements are embedded from the start, is key. From pre-clinical all the way to registration, a well-organized set of action plans needs to be in place that guides and accelerates the client’s vision on how to support their targeted therapeutic area. continue reading…
In 2013, Inez de Greef – van der Sandt was appointed as CEO for our client Treeway, a biotechnology company with a mission to develop therapies to cure ALS. Treeway is a clinical-stage biotechnology company with a mission to develop therapies to cure ALS. It was founded in 2012 by two ALS patients, Bernard Muller continue reading…
© 3D-PharmXchange 2024